Chemotherapy only for localized Hodgkin lymphoma


David J. Straus MD, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
(fax: 646 422 2291; e-mail:


Abstract.  Straus DJ (Memorial Sloan-Kettering Cancer Center, New York, NY, USA). Chemotherapy only for localized Hodgkin lymphoma (Review). J Intern Med 2011; 270: 197–205.

Radiation therapy (RT) alone and more recently in combination with chemotherapy (combined modality therapy; CMT) has been the cornerstone of curative treatment for early-stage Hodgkin lymphoma (HL) for over 40 years. Because of increasing awareness of the late morbidity and mortality associated with RT, recent treatment regimens have attempted to limit its use. Chemotherapy only has been demonstrated to be a treatment option for most patients with localized HL. Current clinical trials have targeted subgroups of such patients who may be at an increased risk of recurrence for the addition of limited RT to chemotherapy.